027-59234612(+86)
EIAab
Home > Monthly new exclusive invent products
GeneName
SQLE(Visit Rating:
)
Journal
Research Area
liver cancer
Abstract
A paper published in Sci Transl Med, reveals a pathogenesis of NAFLD-HCC SQLE is an oncogene of NAFLD-HCC. An anti-fungal drug has the efficacy ofpreventing and treating such liver cancer.
Brochure
Application
The incidence of NAFLD in obese individuals is very high (75% to 100%) About 2.4 to 12.8% of NAFLD patients with cirrhosis progress to HCC. However, there is currently no targeted treatment.
GeneName
SQLE(Visit Rating:
)
Journal
Research Area
liver cancer
Abstract
A paper published in Sci Transl Med, reveals a pathogenesis of NAFLD-HCC SQLE is an oncogene of NAFLD-HCC. An anti-fungal drug has the efficacy ofpreventing and treating such liver cancer.
Brochure
Application
The incidence of NAFLD in obese individuals is very high (75% to 100%) About 2.4 to 12.8% of NAFLD patients with cirrhosis progress to HCC. However, there is currently no targeted treatment.
GeneName
SQLE(Visit Rating:
)
Journal
Research Area
liver cancer
Abstract
A paper published in Sci Transl Med, reveals a pathogenesis of NAFLD-HCC SQLE is an oncogene of NAFLD-HCC. An anti-fungal drug has the efficacy ofpreventing and treating such liver cancer.
Brochure
Application
The incidence of NAFLD in obese individuals is very high (75% to 100%) About 2.4 to 12.8% of NAFLD patients with cirrhosis progress to HCC. However, there is currently no targeted treatment.
1 2 3 4 5 6 7 8 9 10
Page of 10
My Cart close
Attention close
History close
Clear All
Comparison close
User
My Cart
Attention
History
Comparison
Top
Message
close_message
Product Name: *
Email: *
Message: *
Inform
new Message
Package Quantity Price ($) Subtotal 1 ($)
Subtotal 2: $
triangle
Package Quantity Price ($)
Do you want to be our agent and get a lower discount?
Please contact us:
Tel:027-59234612(+86)
Fax:027-59759960(+86)
Email:sales@eiaab.com